CIA
RMD icon

Concurrent Investment Advisors’s ResMed RMD Stock Holding History

Concurrent Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$599K Sell
3,072
-1,930
-39% -$400K 0.01% 1303
2026
Q1 		$1.12M Buy
5,002
+1,950
+64% +$486K 0.01% 830
2025
Q4 		$735K Buy
3,052
+746
+32% +$191K 0.01% 969
2025
Q3 		$631K Buy
2,306
+80
+4% +$21.9K 0.01% 817
2025
Q2 		$574K Buy
2,226
+59
+3% +$14.1K 0.01% 798
2025
Q1 		$485K Buy
2,167
+356
+20% +$83.1K 0.01% 761
2024
Q4 		$414K Sell
1,811
-108
-6% -$26K 0.01% 727
2024
Q3 		$469K Buy
1,919
+57
+3% +$12.7K 0.01% 640
2024
Q2 		$356K Buy
1,862
+678
+57% +$138K 0.01% 683
2024
Q1 		$234K Buy
+1,184
New +$217K 0.01% 747

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Concurrent Investment Advisors's RMD Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its ResMed (RMD) stake by 39% in Q2 2026, selling an estimated $400K and leaving 3,072 shares worth $599K. The position accounts for 0.01% of the portfolio, ranked #1303.

Concurrent Investment Advisors first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.12M in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Concurrent Investment Advisors held 3,072 shares of ResMed worth $599K as of Q2 2026.
  • Concurrent Investment Advisors sold 1,930 ResMed shares in Q2 2026, an estimated $400K.
  • ResMed made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1303 holding.
  • Concurrent Investment Advisors first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Concurrent Investment Advisors's ResMed position peaked at $1.12M in Q1 2026.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.